JP2025504894A5 - - Google Patents

Info

Publication number
JP2025504894A5
JP2025504894A5 JP2024543843A JP2024543843A JP2025504894A5 JP 2025504894 A5 JP2025504894 A5 JP 2025504894A5 JP 2024543843 A JP2024543843 A JP 2024543843A JP 2024543843 A JP2024543843 A JP 2024543843A JP 2025504894 A5 JP2025504894 A5 JP 2025504894A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
binding fragment
seq
fragment according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024543843A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504894A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/061136 external-priority patent/WO2023147292A2/en
Publication of JP2025504894A publication Critical patent/JP2025504894A/ja
Publication of JP2025504894A5 publication Critical patent/JP2025504894A5/ja
Pending legal-status Critical Current

Links

JP2024543843A 2022-01-25 2023-01-24 未分化リンパ腫キナーゼ抗体およびその使用方法 Pending JP2025504894A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263302639P 2022-01-25 2022-01-25
US63/302,639 2022-01-25
PCT/US2023/061136 WO2023147292A2 (en) 2022-01-25 2023-01-24 Anaplastic lymphoma kinase antibodies and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2025504894A JP2025504894A (ja) 2025-02-19
JP2025504894A5 true JP2025504894A5 (cg-RX-API-DMAC7.html) 2026-01-30

Family

ID=87472498

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024543843A Pending JP2025504894A (ja) 2022-01-25 2023-01-24 未分化リンパ腫キナーゼ抗体およびその使用方法

Country Status (9)

Country Link
US (1) US20250101134A1 (cg-RX-API-DMAC7.html)
EP (1) EP4469486A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025504894A (cg-RX-API-DMAC7.html)
KR (1) KR20240135653A (cg-RX-API-DMAC7.html)
CN (1) CN118696064A (cg-RX-API-DMAC7.html)
AU (1) AU2023213840A1 (cg-RX-API-DMAC7.html)
CA (1) CA3248976A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024009078A (cg-RX-API-DMAC7.html)
WO (1) WO2023147292A2 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3066118B1 (en) * 2013-11-06 2020-01-08 The U.S.A. as represented by the Secretary, Department of Health and Human Services Alk antibodies, conjugates, and chimeric antigen receptors, and their use
US11091559B2 (en) * 2015-08-27 2021-08-17 Celldex Therapeutics, Inc. Anti-ALK antibodies and methods for use thereof
WO2019075433A1 (en) * 2017-10-13 2019-04-18 Adimab, Llc ANTIBODIES AGAINST SYNCYTIAL RESPIRATORY VIRUS AND METHODS FOR THEIR GENERATION AND USE
CN112794914B (zh) * 2019-11-14 2022-09-16 深圳华大生命科学研究院 一种基于噬菌体展示技术开发的alk纳米抗体及其应用
CA3168133A1 (en) * 2020-01-28 2021-08-05 The Children's Medical Center Corporation Anaplastic lymphoma kinase chimeric antigen receptors and methods of use

Similar Documents

Publication Publication Date Title
CN110799539B (zh) 抗4-1bb抗体及其制备和使用方法
US12583933B2 (en) Anti-CD73 antibody and use thereof
JP2024096688A5 (cg-RX-API-DMAC7.html)
AU2011295715B9 (en) Novel modulators and methods of use
JP2020534830A5 (cg-RX-API-DMAC7.html)
JP2021525546A5 (cg-RX-API-DMAC7.html)
JP2020525032A5 (cg-RX-API-DMAC7.html)
JP2017535257A5 (cg-RX-API-DMAC7.html)
TW201837174A (zh) 抗gprc5d抗體及包含該抗體之分子
JP2020522513A5 (cg-RX-API-DMAC7.html)
JP2022533538A5 (cg-RX-API-DMAC7.html)
JP2018506961A5 (cg-RX-API-DMAC7.html)
RU2018128215A (ru) Антитела против mica
JP2015163068A5 (cg-RX-API-DMAC7.html)
JP2013519364A5 (cg-RX-API-DMAC7.html)
JP2022515152A5 (cg-RX-API-DMAC7.html)
CA3173257A1 (en) C19 c38 bispecific antibodies
JP2025510642A5 (cg-RX-API-DMAC7.html)
CN110799537A (zh) 抗pd-1抗体及其制备和使用方法
JP2024533457A5 (cg-RX-API-DMAC7.html)
JP2015511216A5 (cg-RX-API-DMAC7.html)
JP7557457B2 (ja) 抗ヒトpd-l1抗体とその使用
JP2020533002A5 (cg-RX-API-DMAC7.html)
AR120430A1 (es) Células car-t dirigidas a epha3 para el tratamiento de tumores
JP2018528210A5 (cg-RX-API-DMAC7.html)